Health-Related Quality of Life (HRQOL) of Pembrolizumab (PEMBRO) vs Standard of Care (SOC) for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) in Keynote-040
Key Publications on immunotherapy and electrochemotherapy
Chairpersons :
Ashok Mehta
Reviewer :
Sushant Mittal